Illumina, Inc. (0J8Z)
LSE
Closed
Aug 25, 2026
Day's Range
218.1852 wk Range
88.58Overview - 0J8Z - Illumina, Inc.
Key Statistics
Valuation
Enterprise Value
34.39B
P/E (Trailing)
‪0.47‬
Price / Sales (TTM)
‪1,391.13‬
Price / Book
‪11.58‬
EV / EBITDA
‪29.77‬
Profitability
Profit Margin
‪18.33%‬
Operating Margin
‪21.13%‬
Return on Assets
‪8.66%‬
Return on Equity
‪32.33%‬
Ownership
Shares Outstanding
147.00M
Float
149.15M
Held by Insiders
‪0.19%‬
Held by Institutions
‪105.90%‬
Price stats
Beta
‪1.46‬
50-Day Avg
‪138.95‬
200-Day Avg
‪149.37‬
Market Cap - 0J8Z - Illumina, Inc.
Peers - 0J8Z - Illumina, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- 0J8ZLSEIllumina, Inc.31.50BMarket Cap+52.31%52-week change0.44P/E (Trailing)‪18.33%‬Profit Margin
- SHCLSEShaftesbury Capital PLC274.79BMarket Cap+1.80%52-week change7.19P/E (Trailing)‪156.72%‬Profit Margin
- MTOLSEMitie Group plc259.56BMarket Cap+31.35%52-week change34.67P/E (Trailing)‪1.47%‬Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.251.64BMarket Cap+21.36%52-week change0.32P/E (Trailing)‪15.03%‬Profit Margin
- 0R2BLSEDanaher Corporation151.20BMarket Cap+4.13%52-week change0.25P/E (Trailing)‪15.94%‬Profit Margin
- 0JDMLSEIQVIA Holdings Inc.52.29BMarket Cap+27.10%52-week change0.47P/E (Trailing)‪8.09%‬Profit Margin
- 0HAVLSEAgilent Technologies Inc.48.67BMarket Cap+22.38%52-week change0.39P/E (Trailing)‪19.55%‬Profit Margin
Profile Summary - 0J8Z - Illumina, Inc.
About
Illumina, Inc. develops, manufactures, and markets sequencing- and array-based solutions for genetic and genomic analysis worldwide, including in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company provides instruments and consumables such as reagents, flow cells, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
